Everbright Securities Co Ltd: A Financial Overview
Everbright Securities Co Ltd, a prominent financial institution in the securities sector, specializes in capital markets. The company offers a range of services including securities brokerage, trading, custody, credit guarantee, underwriting, asset management, and investment consulting. Everbright Securities operates both domestically and internationally and is listed on the Hong Kong Stock Exchange. The company went public on August 18, 2009, and its website is www.ebscn.com .
As of May 18, 2025, Everbright Securities had a close price of 16.53 HKD, with a 52-week high of 22.51 HKD on December 9, 2024, and a 52-week low of 13.49 HKD on July 8, 2024. The market capitalization stood at 70,360,000,000 HKD, and the price-to-earnings ratio was 11.58.
Recent Financial News
Xiaoteng New Material Acquisition: On May 20, 2025, Everbright Securities issued an opinion on the acquisition of minority shareholders’ equity by Jiangsu Xiaoteng New Material Co Ltd and related transactions. The detailed report is available on the CNINFO website.
Xiaomi’s Chip Milestone: Xiaomi’s chip development has exceeded expectations, marking a significant step in domestic chip substitution. The company is set to release its self-developed SoC chip, “Xuanjie O1,” in late May 2025. This positions Xiaomi as the fourth global company to launch a self-developed 3nm process smartphone processor, following Apple, Qualcomm, and MediaTek.
CATL’s Hong Kong Debut: Chinese battery giant CATL saw its shares soar by nearly 17% on its first day of trading on the Hong Kong Stock Exchange on May 20, 2025.
Interest Rate Cuts Boost Financial Sector: Following the People’s Bank of China’s announcement of a reduction in the 1-year and 5-year Loan Prime Rates (LPR), financial stocks experienced a rally. The Bank of China ETF, Tianhong, opened with a nearly 1% increase.
A Shares and Structural Bull Market: The A-share market is poised to enter a new cycle of structural bull market, with the Shanghai-Hong Kong 300 ETF highlighting its value configuration.
Chengda Pharmaceutical Report: Everbright Securities released a 2024 annual tracking report for Chengda Pharmaceutical Co Ltd.
1000ETF Enhanced Performance: The 1000ETF Enhanced saw a rise, with analysts suggesting a potential structural bull market in the future.
Popularity of Robot Stocks: Robot stocks have gained popularity, with several theme parks adopting exoskeleton robots for visitor experiences.
Medical Aesthetics Market Shift: The medical aesthetics market is undergoing a shift, with collagen protein companies like Juzi Biotech and Jinbo Biotech gaining momentum, while hyaluronic acid companies face a slowdown.
Everbright Securities’ Market Position: Everbright Securities continues to play a significant role in the capital markets, providing comprehensive financial services and maintaining a strong market presence.